Faster stroke treatment.
Improve outcomes.
Faster stroke treatment.
Improve outcomes.
When it comes to acute stroke, everyone deserves the best care. Today, more patients can benefit from mechanical thrombectomy through changed guidelines, which widen the time window for endovascular treatment.
Direct to Angio Suite – a one-stop stroke shop
Today more patients can benefit from mechanical thrombectomy through changed guidelines which widen the time to window for endovascular treatment. Direct To Angio Suite workflows allow for comprehensive stroke diagnoses to be performed directly in the neuro angio suite. This provides valuable, timesaving support for critical patients in acute need of mechanical thrombectomy therapy. At Philips, our goal is to help stroke centers shorten door-to-reperfusion times for ischemic stroke by optimizing workflow and protocols, inspired by established STEMI re-perfusion treatment.
The Direct to Angio Suite workflow at a glance
Time to reperfusion is fundamental in reducing morbidity and mortality in acute stroke. In patients presenting directly to an endovascular-capable center, emphasis has now been placed on fast door-to-imaging times and fast imaging to groin access times. Watch the video to see how this works.
Neuro suite & SmartCT
The Philips Neuro suite offers a flexible portfolio of integrated technologies, services, and neuro accessories that puts you in firm control when treating an acute stroke patient.
Our innovative Neuro suite is already delivering advancements in interventional neuroradiology, such as our industry-leading CT-like SmartCT which provides excellent imaging quality to assist interventional neuroradiologists with diagnosis and treatment.
Improving the quality of clinical images
Philips is evaluating in clinical research the optimization of clinically relevant parameters such as increased acquisition speed, improved contrast resolution and optimized artefact correction.1
Avoiding motion artifacts in restless patients, enabling enhanced depiction of bleedings and avoiding cone-beam artefacts, especially in the posterior fossa are important elements of the ongoing research.2
Hemorrhage detection. Comparison between optimized XperCT and Multi Detector CT.3
Want to learn more about the WE TRUST study or the Direct to Angio Suite (DTAS) workflow?
Want to learn more about the WE TRUST study or the Direct to Angio Suite (DTAS) workflow?
1 Image courtesy of Dr. Vitor Mendes Pereira; Toronto Western Hospital, Toronto, CAN 2 Image courtesy of Dr. Vitor Mendes Pereira; Toronto Western Hospital, Toronto, CAN 3 Image courtesy of Dr. Ajay Wakhloo and Dr. Ajit Puri; UMass Medical Center, Worcester, MA, USA. Contains the first clinical results and experience of using investigational XperCT technology. This XperCT technology is considered work in progress and is not CE marked and not available for sale. 4 World Stroke Organization / American Heart Association
